- NISPA (Nijmegen Institute for Scientist-Practitioners in Addiction)

09-2023

Neurocognitive Recovery in Abstinent Patients with Alcohol Use Disorder: A Scoping Review for Associated Factors

Jeroen Staudt, Tim Kok, Hein de Haan, Serge Walvoort en Jos Egger

Dove press, open access to scientific and medical research, Volume 2023:19 Pages 2039—2054 DOI https://doi.org/10.2147/NDT.S424017

Lees meer >

09-2023

Using the Recovery Capital Model to Explore Barriers to and Facilitators of Recovery in Individuals with Substance Use Disorder, Psychiatric Comorbidity and Mild-to-Borderline Intellectual Disability: A Case Series

Esther Pars, Joanneke Van Der Nagel, Boukje Dijkstra en Arnt Schellekens

Journal of clinical medicine 2023, 12(18), 5914; https://doi.org/10.3390/jcm12185914

Lees meer >

06-2023

Rooksignalen: bevorderende en belemmerende factoren bij de invoering van een rookvrije verslavingszorg

Wiebren Markus, Anna Boormans, Boukje Dijkstra en Arnt Schellekens

Tijdschrift Verslaving & Herstel, Vol 3 Nr 2 (2023)

Lees meer >

05-2023

Europe has much to do to improve the quality of and access to safe pain management – Authors' reply

Arno Kalkman, Cornelis Kramers, Wim van den Brink en Arnt Schellekens

Volume 401, Issue 10389, 20–26 May 2023, Pages 1651-1652

Lees meer >

05-2023

Mindfulness-based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change

Hannah Ellerbroek, Imke Hanssen, Karen Lathouwers, Linda Cillessen, Sander Dekkers, Stijn Veldman, Sandra van den Heuvel, Anne Speckens en Arnt Schellekens

Brain en behavior, Volume13, Issue7, July 2023, e3005

Lees meer >

04-2023

Development of an alcohol refusal training in immersive virtual reality for patients with mild to borderline intellectual disability and alcohol use disorder: cocreation with experts in addiction care

Simon Langener, Jan Kolkmeier, Joanneke van der Nagel, Randy Klaassen, Jeannette van Manen en Dirk Heylen

JMIR Form Res 2023;7:e42523

Lees meer >

04-2023

Psychiatric risk factors for chronic high-dose opioid prescribing: register-based cohort study

Mariëlle van der Hoorn, Arno Kalkman, Yvette Weesie, Femke Atsma en Arnt Schellekens

BJPsych Open.2023 Apr 20;9(3):e74.

Lees meer >

04-2023

Patients' perspectives on the development of prescription opioid use disorder in patients with chronic non-cancer pain

Lisa Davies, Ellen Koster, Katinka Damen, Harmen Beurmanjer, Arnt Schellekens en Marcel L Bouvy

Eur Addict Res. 2023 Apr 14;1-9.

Lees meer >

03-2023

An overview of the putative structural and functional properties of the GHBh1 receptor through a bioinformatics approach

Casper Wolf, Hanka Venselaar, Marcia Spoelder, Harmen Beurmanjer, Arnt Schellekens en Judith Homberg

Life 2023, 13(4), 926

Lees meer >

02-2023

Practice variation in opioid prescribing for non-cancer pain in Dutch primary care: A retrospective database study

Arno Kalkman, Cornelis Kramers, R T van Dongen, Henk Schers , Rianne van Boekel, Anne-Marie Bos, Karin Hek, Arnt Schellekens en Femke Atsma

PLoS One. 2023 feb 24;18(2):e0282222

Lees meer >

02-2023

Invloed van soort middelengebruik, geslacht en psychische comorbiditeit op recidiverisico

Michelle van Harskamp, Laura DeFuentes-Merillas, Hanneke van Gestel-Timmermans, Lisa Knapen

Tijdschrift Psychiatrie. 2023;65(6):362-367

Lees meer >

02-2023

Therapeutic effect of psilocybin in addiction: A systematic review

Pim van der Meer, Juan Fuentes, Ad Kaptein, Jan Schoones, Marleen de Waal, Anneke Goudriaan, Kees Kramers, Arnt Schellekens, Metten Somers, Matthijs Bossong en Albert Batalla

Front Psychiatry. 2023 Feb 9;14:1134454.

Lees meer >

02-2023

Therapeutic effect of psilocybin in addiction: A systematic review

Pim van der Meer, Juan Fuentes, Ad Kaptein, Jan Schoones, Marleen de Waal, Anneke Goudriaan, Kees Kramers, Arnt Schellekens, Metten Somers, Matthijs Bossong en Albert Batalla

Front Psychiatry. 2023 feb 9;14:1134454.

Lees meer >

01-2023

Cannabis-opioid interaction in the treatment of fibromyalgia pain: an open-label, proof of concept study with randomization between treatment groups: cannabis, oxycodone or cannabis/oxycodone combination-the SPIRAL study

Cornelis Jan van Dam, Monique van Velzen, Cornelis Kramers, Arnt Schellekens, Erik Olofsen, Marieke Niesters en Albert Dahan

Randomized Controlled Trial Trials, 2023, 24(1): 64

Lees meer >

01-2023

Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study

Pauline Geuijen, Arnt Schellekens, Aart Schene en Femke Atsma

Addiction Science Clinical Practice, 2023, 18(1): 4

Lees meer >